LFMD - LifeMD: Moving Towards Profitability

2024-05-22 19:11:31 ET

Summary

• LifeMD, Inc. shares have been volatile over the past year, pulling back 50% from recent highs, but still having tripled in the past 12 months.
• GLP-1 drugs like Zepbound and Wegovy have helped turbocharge growth in LifeMD's weight management business.
• The company is delivering impressive and consistent sales growth and is projected to be profitable by FY2025.
• An updated analysis around LifeMD is presented in the paragraphs below.

We last revisited LifeMD, Inc. ( LFMD ) in July 2023. The shares of this direct-to-patient telehealth platform have been volatile since then. Recently, they have pulled back some 50% from recent highs, but still have more than tripled over the past year. Where do the shares go from here? An updated analysis follows below....

For further details see: